Related Experiment Video
Updated: Sep 27, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Clinical and epidemiological aspects of cardiomyopathies: a critical review of current knowledge
1Department of Internal Medicine, University of Tor Vergata, Rome, Italy
Insights
This review clarifies cardiomyopathies (CM), defining them as direct myocardial injuries, not consequences of other conditions. It proposes a classification based on morpho-functional alterations and etiology for better understanding and diagnosis.
Area of Science:
- Cardiology
- Pathology
- Genetics
Background:
- Current definitions of cardiomyopathies (CM) are often confused by terms like ischemic or hypertensive CM.
- Myocardial injury encompasses macroscopic, subcellular, ultrastructural, and molecular damage, including genetic origins.
- CM manifestations include ventricular dysfunction and bioelectric defects like arrhythmias.
Purpose of the Study:
- To critically review and refine the definition and classification of cardiomyopathies.
- To propose a classification based on morpho-functional alterations and etiology.
- To clarify the concept of myocardial injury in the context of CM.
Main Methods:
- Critical review of existing literature and classifications of cardiomyopathies.
- Analysis of the concept of myocardial injury, including its various levels of manifestation.
- Synthesis of etiopathogenetic, pathophysiological, and clinical features for classification.
Main Results:
- Cardiomyopathies are defined as direct myocardial injuries, distinct from ischemic or overload conditions.
- Proposed classification includes dilated (hypokinetic), hypertrophic, restrictive, and arrhythmogenic CM, with mixed forms.
- Distinction between specific (known cause) and primary/idiopathic CM (including genetic forms) is maintained.
Conclusions:
- A refined definition and classification of cardiomyopathies are essential for accurate diagnosis and understanding.
- Recognizing myocardial injury as the core pathology, at multiple levels, is crucial.
- This framework aims to encompass current knowledge for a comprehensive clinical-epidemiological setting.
Abstract:
Five years after the second report of the WHO/ISFC Task Force on the definition and classification of cardiomyopathies (CM), a critical review of the matter appears well-timed. The need for a correct definition of myocardial diseases is emphasized by considering them the result of a 'direct' injury due to different known and unknown causes and not a consequence of ischemic disease or of pressure and/or volume overload. This is in order to eliminate terms like ischemic CM, valvular CM, and hypertensive CM, which are a source of confusion. The concept of myocardial injury is also reviewed. This should not only include the structural/organic macroscopic injury, but also the subcellular, ultrastructural, and molecular damage (mostly of genetic origin) of the contracting element proteins, of citosol, sarcolemma and cell membrane ion channels. As the myocardium is a complex structure, made of common fibers and of specific conduction tissue, injury may be clinically identified either by ventricular function impairment or by bioelectric function defects, i.e. tachyarrhythmias and/or bradyarrhythmias, which sometimes are the unique manifestation of the disease (arrhythmogenic CM, in the strict sense). On the basis of the morpho-functional alterations, CMs may be classified as dilated CM (which could be better identified as hypokinetic CM, referring to the functional aspect, because the morphologic aspect is not always present), hypertrophic CM, restrictive CM, and arrhythmogenic CM (including not only arrhythmogenic right ventricular CM, but also other forms, like the so-called arrhythmias of the 'apparently' healthy heart, due to 'occult' myocardial injury). Moreover, these forms may present in association, like mixed CM (dilated-arrhythmogenic, dilated-hypertrophic, etc.). From an etiologic point of view, it is advisable to maintain the distinction between specific CM, due to a known cause, and primary or idiopathic CM, including, together with sporadic forms of an unknown origin, familial forms of a genetic origin, depending on alterations of contractile or regulating functional proteins, when myocardial injury is the sole manifestation (idiopathic) of clinical picture. The most modern etiopathogenetic, pathophysiological, and clinical features of each form of CM are briefly described in order to suggest a complete definition of the disease and to state a clinical-epidemiological setting that encompasses the current knowledge.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy

